Hematological cellular alterations in plateletpheresis donors
International Journal of Blood Transfusion and Immunohematology · 2018
DOI: 10.5348/100041z02hf2018oa ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Blood Transfusion and Immunohematology, 2018. Verfasst von Hanan Mahmoud Fayed und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Aims
Blood contact with foreign surfaces in the apheresis systems may activate many cell types that return back to the donor. However, the safety issue regarding post-procedure platelet activation is not well assessed. We aimed to evaluate the alterations in hematological parameters and to explore the formation of platelets leukocytes aggregates (PLAs) and/or complexes in healthy donors who underwent first-time plateletpheresis procedure.
Methods
Blood from 100 healthy donors were assessed by BD FACS Calibur flow cytometer for: a) detection of PLAs using (CD41, CD42b, CD61) antibodies against platelets surface molecules to detect its expression on neutrophils, monocytes, lymphocytes, and b) evaluation of red cell mechanical fragility (RBC-MF).
Results
After donation a significant decrement of donor blood cell counts; the percent (%) reduction in hemoglobin (Hb) 7.9(5.1–9.2) (p = 0.017), hematocrit (Hct) 6(2.72-7.81) (p = 0.043) %, residual red cells (p = 0.016), platelet count (PLT) 22.7(9.5–32) (p = 0.031) together with a significant increase in the MPV (p = 0.001), the absolute neutrophil (p = 0.026) and lymphocyte count (p = 0.041) with an insignificant increase in absolute monocyte (p = 0.103), lymphocyte subsets count, CD4:CD8 ratio, and WBC count. However, there was significant increase in the median platelets complexed with neutrophil, lymphocytes, and monocytes.
Conclusion
All donors had a significant drop in all blood counts; none of them manifested features of thrombocytopenia or anemia. However, an increase in PLAs formation provides an evidence of ongoing platelet activation, a platelet-leucocyte interaction that may induce a pre-thrombotic risk. This result is important to consider as it might have potential therapeutic implications. Nevertheless, more prospective studies are essential to establish guidelines for donor safety.
Zitieren
APA
Fayed, H. M., Ali, S. S., & Eldin, E. S. (2018). Hematological cellular alterations in plateletpheresis donors. International Journal of Blood Transfusion and Immunohematology. https://doi.org/10.5348/100041z02hf2018oa
Vancouver
Fayed HM, Ali SS, Eldin ES. Hematological cellular alterations in plateletpheresis donors. International Journal of Blood Transfusion and Immunohematology. 2018. doi:10.5348/100041z02hf2018oa
BibTeX
@article{Fayed2018,
author = {Fayed, Hanan Mahmoud and Ali, Sanaa Shaker and Eldin, Eman Salah},
title = {Hematological cellular alterations in plateletpheresis donors},
journal = {International Journal of Blood Transfusion and Immunohematology},
year = {2018},
doi = {10.5348/100041z02hf2018oa}
}
EUVIMED